J&J, Bristol Myers Squibb Lose Challenges in Medicare Drug Price Negotiations
Jonathan Raá | Nurfoto | fake images A federal judge in New Jersey on Monday rejected Johnson and Johnson'sand Bristol-Myers…
Bristol-Myers Squibb Co.
Biotech stocks are ready to break out. They just need one more thing
As debate continues over when the Federal Reserve might begin cutting interest rates, biotech industry analysts argue that the case…
J&J cell therapy gains advantage over Bristol Myers rival
Jonathan Raá | Nurfoto | fake images Do you think a friend or colleague should receive this newsletter? Share this…
Medicare drug price negotiations: Judge rejects AstraZeneca challenge
Activists protest prescription drug pricing outside the US Department of Health and Human Services building in Washington, DC, on October…
Medicare Drug Price Negotiations: Judge Dismisses PhRMA Lawsuit
Activists protest prescription drug pricing in front of the U.S. Department of Health and Human Services (HHS) building on October…
CEOs of Merck, J&J and Bristol Myers Squibb face Senate hearing on drug prices
Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey about issuing subpoenas for drug company CEOs…
J&J, Merck and Bristol Myers Squibb on the bench
Do you think a friend or colleague should receive this newsletter? Share this link with them to register. Good afternoon!…
Fourth-quarter earnings set to be best of 2023
Traders work at the New York Stock Exchange (NYSE) in New York City, USA, on February 1, 2024. Brendan McDermid…
Here are Jim Cramer's quick takeaways on 6 stocks in Friday's news
Clorox: The consumer products giant saw a huge increase in profits. It is also recovering from last year's cyberattack. “Things…
Bristol Myers Squibb (BMY) Q4 2023 Earnings Report
Bristol-Myers Squibb reported quarterly earnings and revenue on Friday that beat expectations as its portfolio of new drugs posted strong…